Abstract
Erythropoietin (EPO), already known as the stimulating hormone for erythropoiesis, has shown different and interesting pleiotropic actions. It does not only affect erythroid cells, but also myeloid cells, lymphocytes and megakaryocytes. This hormone can also enhance phagocytic function of the polymorphonuclear cells and reduce the activation of macrophages, thus modulating the inflammatory process.Moreover, hematopoietic and endothelial cells probably have the same cellular origin, and the discovery of erythropoietin receptors (EPO-R) also on mesangial and myocardial cells, smooth muscle fibrocells and neurons has prompted the study of the non-erythropoietic functions of this hormone.The interaction between EPO and VEGF may be of particular importance in neovascularization and wound healing.Different studies have demonstrated that EPO has an important direct hemodynamic and vasoactive action, which does not depend exclusively on any increase in hematocrit and viscosity. Moreover EPO showed protective effects on myocardial cells against apoptosis induced by ischemia/repefusion injury, but it could negatively affect pulmonary hypertension in patient with chronic cor pulmonale.This review aims to stress the importance of the increasing interest in EPO applications and the necessity of further studies to gain a deeper knowledge of this hormone and its pleiotropic and complex actions.
Keywords: Erythropoietin (EPO), pleiotropic action, receptors, oxygen tension, apoptosis, angiogenesis, ischemia
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title: From the Oxygen to the Organ Protection: Erythropoietin as Protagonist in Internal Medicine
Volume: 4 Issue: 4
Author(s): M. Buemi, L. Nostro, M. S. Giacobbe, C. Aloisi, A. Sturiale, D. Bolignano, A. Allegra, G. Grasso and N. Frisina
Affiliation:
Keywords: Erythropoietin (EPO), pleiotropic action, receptors, oxygen tension, apoptosis, angiogenesis, ischemia
Abstract: Erythropoietin (EPO), already known as the stimulating hormone for erythropoiesis, has shown different and interesting pleiotropic actions. It does not only affect erythroid cells, but also myeloid cells, lymphocytes and megakaryocytes. This hormone can also enhance phagocytic function of the polymorphonuclear cells and reduce the activation of macrophages, thus modulating the inflammatory process.Moreover, hematopoietic and endothelial cells probably have the same cellular origin, and the discovery of erythropoietin receptors (EPO-R) also on mesangial and myocardial cells, smooth muscle fibrocells and neurons has prompted the study of the non-erythropoietic functions of this hormone.The interaction between EPO and VEGF may be of particular importance in neovascularization and wound healing.Different studies have demonstrated that EPO has an important direct hemodynamic and vasoactive action, which does not depend exclusively on any increase in hematocrit and viscosity. Moreover EPO showed protective effects on myocardial cells against apoptosis induced by ischemia/repefusion injury, but it could negatively affect pulmonary hypertension in patient with chronic cor pulmonale.This review aims to stress the importance of the increasing interest in EPO applications and the necessity of further studies to gain a deeper knowledge of this hormone and its pleiotropic and complex actions.
Export Options
About this article
Cite this article as:
Buemi M., Nostro L., Giacobbe S. M., Aloisi C., Sturiale A., Bolignano D., Allegra A., Grasso G. and Frisina N., From the Oxygen to the Organ Protection: Erythropoietin as Protagonist in Internal Medicine, Cardiovascular & Hematological Agents in Medicinal Chemistry 2006; 4(4) . https://dx.doi.org/10.2174/187152506778520754
DOI https://dx.doi.org/10.2174/187152506778520754 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Novel Therapeutics for Diabetic Micro- and Macrovascular Complications
Current Medicinal Chemistry The Cannabinoids Switch of Oxidative Stress: A Double-Edged Sword
Mini-Reviews in Organic Chemistry Scorpion Toxin Polyptides as Therapeutic Agents: An Overview
Protein & Peptide Letters Haemodynamic Regulation of Gene Expression in Vascular Tissue Engineering
Current Vascular Pharmacology Endotoxin, TLR4 Signaling and Vascular Inflammation: Potential Therapeutic Targets in Cardiovascular Disease
Current Pharmaceutical Design Cushing's Syndrome and Steroid Dementia
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Serum Uric Acid is Independently Associated with Diastolic Dysfunction in Apparently Healthy Subjects with Essential Hypertension
Current Vascular Pharmacology Treatment of Carotid Stenosis
Current Vascular Pharmacology Secretase-Mediated Cell Surface Shedding of the Angiotensin-Converting Enzyme
Protein & Peptide Letters Endocrine Therapies and QTc Prolongation
Current Drug Safety Synthesis, Cytotoxicity and Molecular Docking Simulation of Novel bis-1,4-Dihydropyridines Linked to Aliphatic or Arene Core via Amide or Ester-Amide Linkages
Mini-Reviews in Medicinal Chemistry Tissue Factor and Hypertension
Current Hypertension Reviews Post-Translational Protein Modifications of Rare and Unconventional Types: Implications in Functions and Diseases
Current Medicinal Chemistry Ascorbic acid-Catalyzed One-Pot Three-Component Biginelli Reaction: A Practical and Green Approach towards Synthesis of 3,4-dihydropyrimidin- 2(1H)-ones/thiones
Letters in Organic Chemistry Latest Advances in Breast Sonography
Recent Patents on Medical Imaging (Discontinued) Urate Transport: Regulators of Serum Urate Levels in Humans
Current Rheumatology Reviews Acute Phase Treatment of Pulmonary Embolism
Current Vascular Pharmacology Editorial: [Challenges on the Improvement of Global Maternal Health]
Current Women`s Health Reviews Treatment of Obesity: Should We Target the Individual or Society?
Current Pharmaceutical Design Endothelial Lessons
Current Vascular Pharmacology